Matches in Wikidata for { <http://www.wikidata.org/entity/Q37437381> ?p ?o ?g. }
- Q37437381 description "article científic" @default.
- Q37437381 description "article scientifique" @default.
- Q37437381 description "articolo scientifico" @default.
- Q37437381 description "artigo científico" @default.
- Q37437381 description "artículu científicu espublizáu en 2016" @default.
- Q37437381 description "bilimsel makale" @default.
- Q37437381 description "scientific article published on 15 May 2016" @default.
- Q37437381 description "vedecký článok" @default.
- Q37437381 description "vetenskaplig artikel" @default.
- Q37437381 description "videnskabelig artikel" @default.
- Q37437381 description "vědecký článek" @default.
- Q37437381 description "wetenschappelijk artikel" @default.
- Q37437381 description "wissenschaftlicher Artikel" @default.
- Q37437381 description "наукова стаття, опублікована в травні 2016" @default.
- Q37437381 description "научни чланак" @default.
- Q37437381 description "مقالة علمية نشرت في 15 مايو 2016" @default.
- Q37437381 name "GFOD1 and peejar are promising markers for clear-cell renal cell carcinoma disease progression" @default.
- Q37437381 name "GFOD1 and peejar are promising markers for clear-cell renal cell carcinoma disease progression" @default.
- Q37437381 name "GFOD1 and peejar are promising markers for clear-cell renal cell carcinoma disease progression" @default.
- Q37437381 type Item @default.
- Q37437381 label "GFOD1 and peejar are promising markers for clear-cell renal cell carcinoma disease progression" @default.
- Q37437381 label "GFOD1 and peejar are promising markers for clear-cell renal cell carcinoma disease progression" @default.
- Q37437381 label "GFOD1 and peejar are promising markers for clear-cell renal cell carcinoma disease progression" @default.
- Q37437381 prefLabel "GFOD1 and peejar are promising markers for clear-cell renal cell carcinoma disease progression" @default.
- Q37437381 prefLabel "GFOD1 and peejar are promising markers for clear-cell renal cell carcinoma disease progression" @default.
- Q37437381 prefLabel "GFOD1 and peejar are promising markers for clear-cell renal cell carcinoma disease progression" @default.
- Q37437381 P1433 Q37437381-4C0CA01A-3B7F-4001-989C-FE38D6156307 @default.
- Q37437381 P1476 Q37437381-99855DE1-09D8-4596-A21E-B7988E1F3E00 @default.
- Q37437381 P2093 Q37437381-40FBABD6-175E-4CA0-8392-CEB181CF6396 @default.
- Q37437381 P2093 Q37437381-55558B2E-65CE-4382-9FC3-E4996089E69B @default.
- Q37437381 P2093 Q37437381-5C8EE1EB-C798-41F6-BBC2-5EA8B7C0D753 @default.
- Q37437381 P2093 Q37437381-71CF383F-B894-4623-97F7-53F705B1202C @default.
- Q37437381 P2093 Q37437381-97A05CCD-8209-4D1F-99DA-607EDE4EC58B @default.
- Q37437381 P2093 Q37437381-99D7451D-AB1C-4DC8-827B-0EB0F955C713 @default.
- Q37437381 P2093 Q37437381-BF447879-AAB9-43D9-89DE-324591F95CD3 @default.
- Q37437381 P2093 Q37437381-DB6D0E3D-C943-4705-B65F-82B741B95A64 @default.
- Q37437381 P2093 Q37437381-E4A46B50-658A-4A7F-9861-2519D6286C8A @default.
- Q37437381 P2860 Q37437381-0706E827-7131-43E1-A429-4FB1A801A6DB @default.
- Q37437381 P2860 Q37437381-091D9A05-6CEF-4F86-A2F9-3718B23DAD05 @default.
- Q37437381 P2860 Q37437381-0DAB3C1E-5BC4-452D-BEB0-3FCC829F8047 @default.
- Q37437381 P2860 Q37437381-1A7D6B51-EC47-4D22-AFD8-889F82E16A09 @default.
- Q37437381 P2860 Q37437381-22003295-B6FA-4EEC-9E0C-A3D6B171AE9B @default.
- Q37437381 P2860 Q37437381-2F2992E5-566D-4025-B7F0-70D9F544102B @default.
- Q37437381 P2860 Q37437381-33C7414C-A5F7-4841-A1A7-2C0340328E07 @default.
- Q37437381 P2860 Q37437381-343D00F6-43A4-4693-A69A-269DCEDF0094 @default.
- Q37437381 P2860 Q37437381-37DCA98F-AE1D-45DD-97F2-77DE4BB89D16 @default.
- Q37437381 P2860 Q37437381-4FBBE410-C741-4585-B090-A1FD92EFAD6F @default.
- Q37437381 P2860 Q37437381-5112CDA9-1157-4715-89BD-BA89F7A0EBC4 @default.
- Q37437381 P2860 Q37437381-53B1C351-A06F-459D-8F31-E136C9ADA7D1 @default.
- Q37437381 P2860 Q37437381-5BFDB4C0-AB39-480A-9391-6AD4120AEA6D @default.
- Q37437381 P2860 Q37437381-60EAF765-1474-4EC4-9FC4-525918402741 @default.
- Q37437381 P2860 Q37437381-65187749-2DA6-4F19-A70E-E2C3F10EBE95 @default.
- Q37437381 P2860 Q37437381-6A7E93F8-2A5E-4BE2-AFAD-8B2C92C9686C @default.
- Q37437381 P2860 Q37437381-717FCC3A-16D3-4D44-AAB8-868664978823 @default.
- Q37437381 P2860 Q37437381-8091E2A7-EA4C-4771-9988-E2B9E2F5052A @default.
- Q37437381 P2860 Q37437381-8AB9D210-547E-4E85-8842-893E047C07A0 @default.
- Q37437381 P2860 Q37437381-8AF63449-9D65-4C80-A6BF-DBC1A56DECE5 @default.
- Q37437381 P2860 Q37437381-A69DF405-90AE-4D62-B51A-F1AC72274C2F @default.
- Q37437381 P2860 Q37437381-A8FC4EEE-8C0D-4C9E-B897-A1819F448236 @default.
- Q37437381 P2860 Q37437381-C39EA0ED-60FA-41E0-8CE5-624A03F5741B @default.
- Q37437381 P2860 Q37437381-C5FAFAF1-8DF8-4708-A71A-ECB72349EB35 @default.
- Q37437381 P2860 Q37437381-CB4B79B5-7D9F-4795-956C-53F9B20F2358 @default.
- Q37437381 P2860 Q37437381-D022CAC3-3D72-4761-9F60-12815338CF34 @default.
- Q37437381 P2860 Q37437381-E596E235-CA9A-4321-B81E-88FB83F3D439 @default.
- Q37437381 P2860 Q37437381-F98ACCDF-DD15-407D-BB18-2E220A0F8741 @default.
- Q37437381 P2860 Q37437381-FF99ADAE-30CF-4CC4-A095-6D0FCBE6B5C9 @default.
- Q37437381 P304 Q37437381-992943E5-A8C7-4B50-A80A-BD0D958CB5B4 @default.
- Q37437381 P31 Q37437381-4E1A1540-5631-4501-AA24-1BFC076EBF7E @default.
- Q37437381 P356 Q37437381-140A5BA0-EFED-4136-AD52-DE7515DDC7ED @default.
- Q37437381 P407 Q37437381-8CE25C7E-8618-41B0-AE20-8FD2ADF1D395 @default.
- Q37437381 P433 Q37437381-E56AD611-90F0-4C91-B294-6E6752BBD45A @default.
- Q37437381 P478 Q37437381-DD2FB424-3C73-4855-AD1D-5A884995B6C0 @default.
- Q37437381 P577 Q37437381-8511230D-A136-4D67-AFB6-AB876B73C386 @default.
- Q37437381 P698 Q37437381-54E30EB5-38BB-4323-90A3-DF905C64782D @default.
- Q37437381 P921 Q37437381-A04D6777-C03B-44C2-9B4D-733835FC1AE3 @default.
- Q37437381 P932 Q37437381-052434D0-BFAE-4BDF-90A9-5CE03285F31F @default.
- Q37437381 P356 ONCOTARGET.9379 @default.
- Q37437381 P698 27191742 @default.
- Q37437381 P1433 Q1573155 @default.
- Q37437381 P1476 "GFOD1 and peejar are promising markers for clear-cell renal cell carcinoma disease progression" @default.
- Q37437381 P2093 "Dong-Ming Liu" @default.
- Q37437381 P2093 "Ji-Wei Huang" @default.
- Q37437381 P2093 "Jin Zhang" @default.
- Q37437381 P2093 "Wei Chen" @default.
- Q37437381 P2093 "Wei Xue" @default.
- Q37437381 P2093 "Wen Kong" @default.
- Q37437381 P2093 "Xiao-Rong Wu" @default.
- Q37437381 P2093 "Yi-Ran Huang" @default.
- Q37437381 P2093 "Yong-Hui Chen" @default.
- Q37437381 P2860 Q21184141 @default.
- Q37437381 P2860 Q27860576 @default.
- Q37437381 P2860 Q27861098 @default.
- Q37437381 P2860 Q28710193 @default.
- Q37437381 P2860 Q29614331 @default.
- Q37437381 P2860 Q29614937 @default.
- Q37437381 P2860 Q29616172 @default.
- Q37437381 P2860 Q29618027 @default.
- Q37437381 P2860 Q31032840 @default.
- Q37437381 P2860 Q33721461 @default.
- Q37437381 P2860 Q33898834 @default.